Interestingly, any of these two events was sufficient to promote the formation of prostate cancer, but only the functional synergy of the oncogenic function of AR and KRAS signaling could promote prostate cancer progenitors in vivo and elevate EZH2 expression [551]. The gene discussed is EZH2; the disease is prostate cancer.